The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline
Research Funding - Amgen; Celgene; Genentech; GlaxoSmithKline; Janssen
DREAMM-2: Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) and high-risk (HR) cytogenetics.
 
Adam D. Cohen
Consulting or Advisory Role - Celgene; GlaxoSmithKline; Janssen Oncology; Kite, a Gilead company; Oncopeptides; Seagen; Takeda
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to CAR T cells and biomarkers of Cytokine Release Syndrome
Expert Testimony - Janssen Oncology
Travel, Accommodations, Expenses - Celgene; GlaxoSmithKline; Janssen Oncology; Janssen Oncology; Takeda
 
Suzanne Trudel
No Relationships to Disclose
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Edward N. Libby
Consulting or Advisory Role - Adaptive Biotechnologies; Akcea Therapeutics; Pharmacyclics
 
Hans Chulhee Lee
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Research Funding - Amgen; Celgene; Daiichi Sankyo; GlaxoSmithKline; Janssen; Takeda
 
Britta Besemer
Honoraria - Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag
 
Thierry Facon
No Relationships to Disclose
 
Ajay K. Nooka
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Spectrum Pharmaceuticals; Takeda
Research Funding - Amgen (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Natalie Scott Callander
Research Funding - Cellectar
 
Ajai Chari
Consulting or Advisory Role - Amgen; Antengene; Bristol-Myers Squibb; Celgene; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Novartis; OncoPeptides; Seagen; Secura Bio; Takeda
Research Funding - Amgen; Celgene; Janssen; Novartis; Pharmacyclics; Seagen; Takeda
 
Ira Gupta
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Sofia Paul
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Joanna Opalinska
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline (Inst)
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)